BW-20805-2-1001

· Shanghai Argo Biopharmaceutical Co., Ltd.

Drug timelines are a Plus or Pro feature.

1 regulatory and trial event tracked for BW-20805-2-1001, covering 2026-04-21 to 2026-04-21. Get the full timeline:

Most recent: Clinical Trial Update: A Phase 1 Clinical Study of BW-20805-2-1001 in Healthy Participants [Phase 1]